M. Puigdellívol

发表

Effective Knockdown of Gene Expression in Primary Microglia With siRNA and Magnetic Nanoparticles Without Cell Death or Inflammation

Guy C. Brown, M. Burguillos, J. L. Venero, 2018, Front. Cell. Neurosci..

Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration

Guy C. Brown, M. Puigdellívol, David H Allendorf, 2020, Frontiers in Cellular Neuroscience.

Activated microglia desialylate their surface, stimulating complement receptor 3‐mediated phagocytosis of neurons

Guy C. Brown, M. Puigdellívol, David H Allendorf, 2019, Glia.

BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome

P. Lombroso, Jian Xu, A. Saavedra, 2016, Molecular Neurobiology.

Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, while the Alzheimer’s R47H mutant does the opposite

D. Klenerman, P. S. St George-Hyslop, P. Fraser, 2020, bioRxiv.

Calreticulin and Galectin-3 Opsonise Bacteria for Phagocytosis by Microglia

Guy C. Brown, M. Puigdellívol, Thomas Cockram, 2019, Front. Immunol..

Imbalance of p75NTR/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies

A. Giralt, J. Alberch, M. Puigdellívol, 2013, Cell Death and Disease.

The dopaminergic stabilizer, (−)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins

M. Mena, M. Casarejos, J. Alberch, 2012, Brain Research.

Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner.

A. Saavedra, J. Alberch, E. Pérez-Navarro, 2017, Biochimica et biophysica acta. General subjects.

Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice

Guy C. Brown, M. Puigdellívol, A. Vilalta, 2021, Journal of neuroinflammation.

Ikzf1 as a novel regulator of microglial homeostasis in inflammation and neurodegeneration

X. Gasull, A. Giralt, J. Alberch, 2023, Brain, Behavior, and Immunity.

Microglial phagocytosis of neurons in neurodegeneration, and its regulation

Guy C. Brown, M. Puigdellívol, C. Butler, 2021, Journal of neurochemistry.

Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum

F. Ciruela, C. Lluis, B. Lutz, 2017, Neuropsychopharmacology.

Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.

A. Giralt, J. Alberch, J. Valero, 2012, Human molecular genetics.

Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF

A. Saavedra, E. Pérez-Navarro, M. Puigdellívol, 2016, Brain pathology.

Ikzf1 as a novel regulator of microglial homeostasis in inflammation and neurodegeneration

X. Gasull, A. Giralt, J. Alberch, 2023, Brain, Behavior, and Immunity.

P2Y6 receptor‐dependent microglial phagocytosis of synapses mediates synaptic and memory loss in aging

Guy C. Brown, M. Puigdellívol, R. Butler, 2022, Aging cell.

Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation

D. Klenerman, P. S. St George-Hyslop, P. Fraser, 2021, The Journal of biological chemistry.

Cdk5-mediated mitochondrial fission: A key player in dopaminergic toxicity in Huntington's disease.

J. Alberch, M. Puigdellívol, S. Ginés, 2015, Biochimica et biophysica acta.

Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.

Eduardo D. Martín, Lilian Enriquez-Barreto, M. Morales, 2014, The Journal of clinical investigation.

The microglial P2Y6 receptor mediates neuronal loss and memory deficits in neurodegeneration

M. Spillantini, V. Borutaite, Guy C. Brown, 2021, Cell reports.

A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease.

Eduardo D. Martín, B. Eipper, A. Giralt, 2015, Human molecular genetics.

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease

M. Scarselli, C. Lluis, S. Ferré, 2020, eLife.

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease

M. Scarselli, C. Lluis, S. Ferré, 2019, bioRxiv.

BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome

P. Lombroso, Jian Xu, A. Saavedra, 2016, Molecular Neurobiology.

Cdk5 Contributes to Huntington’s Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates

J. Bibb, F. Plattner, J. Alberch, 2017, Molecular Neurobiology.

Cdk5 Contributes to Huntington’s Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates

J. Bibb, F. Plattner, J. Alberch, 2017, Molecular Neurobiology.

[Sexual dysfunction with antidepressive agents. Effect of the change to amineptine in patients with sexual dysfunction secondary to SSRI].

M. Bousoño, A. Montejo, J. Carrasco, 1999, Actas espanolas de psiquiatria.

Nociceptive behaviour and lumbar spinal NADPH-d/NOS, p-ERK AND c-FOS expression after formalin pain induction in weaned rats

M. Mena, M. Casarejos, I. Rubio, 2012, International Journal of Developmental Neuroscience.

Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.

Eduardo D. Martín, M. Morales, A. Giralt, 2014, The Journal of clinical investigation.